Doctor profile · Federal record
Dr. Dennis Moore, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Wichita, KS
- NPI 1043272305
- Accepts Medicare
- MIPS 67.4 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
818 N Emporia St, Suite 403
Wichita, KS 672143729
(316) 262-4467
fax (316) 262-0706 - Mailing address
-
818 N Emporia St Ste 403
Wichita, KS 672143728
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- April 8, 2026
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Kansas #0423400
- Medicaid
- KS #100159600B
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043272305. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
394,089
Distinct HCPCS
10
Medicare allowed
$8,475,762
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 43,500 | 41 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 36,000 | 62 | $54 | |
J0185 |
Injection, aprepitant, 1 mg | 34,320 | 142 | $2 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 30,000 | 31 | $1 | |
J1627 |
Injection, granisetron, extended-release, 0.1 mg | 19,400 | 112 | $6 | |
J9299 |
Injection, nivolumab, 1 mg | 19,020 | 24 | $30 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 19,018 | 33 | $0 | |
J9145 |
Injection, daratumumab, 10 mg | 15,340 | 29 | $60 | |
J0897 |
Injection, denosumab, 1 mg | 15,300 | 96 | $24 | |
J9267 |
Injection, paclitaxel, 1 mg | 14,814 | 37 | $0 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 3,258. This provider delivers 121× the peer median.Open Payments
Industry payments received
All-time total
$2,637
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $300.46 | |
| ABBVIE INC. | 18 | $265.45 | |
| Astellas Pharma US Inc | 6 | $256.22 | |
| AstraZeneca Pharmaceuticals LP | 4 | $174.51 | |
| Celgene Corporation | 10 | $147.88 | |
| Daiichi Sankyo Inc. | 5 | $137.14 | |
| Myriad Genetic Laboratories, Inc. | 1 | $101.28 | |
| Merck Sharp & Dohme LLC | 5 | $89.73 | |
| GlaxoSmithKline, LLC. | 4 | $80.07 | |
| GENZYME CORPORATION | 4 | $72.65 | |
| SOBI, INC | 3 | $68.16 | |
| Gilead Sciences, Inc. | 4 | $66.55 | |
| Lilly USA, LLC | 1 | $61.99 | |
| EMD Serono, Inc. | 4 | $61.69 | |
| PFIZER INC. | 3 | $59.89 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,256
Patients
322
Total drug cost
$1,747,037
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 241 | 61 | $12,643 |
| Acyclovir | Generic | 192 | 36 | $4,005 |
| Dexamethasone | Generic | 136 | 45 | $1,625 |
| Prednisone | Generic | 102 | 34 | $433 |
| Ondansetron Hcl | Generic | 100 | 66 | $2,380 |
| Eliquis (Apixaban) | Brand | 71 | 17 | $57,954 |
| Hydroxyurea | Generic | 67 | 18 | $2,595 |
| Levothyroxine Sodium | Generic | 62 | 16 | $567 |
| Pomalyst (Pomalidomide) | Brand | 60 | 0 | $1,253,454 |
| Venclexta (Venetoclax) | Brand | 44 | 0 | $270,506 |
Hospital affiliations
Frequently asked questions
What is Dr. Dennis Moore's medical specialty?
Dr. Dennis Moore practices Hematology & Oncology Physician in Wichita, KS.
Where does Dr. Dennis Moore practice?
Dr. Dennis Moore practices at 818 N Emporia St, Wichita, KS 672143729. Office phone: 3162624467.
What is Dr. Dennis Moore's NPI?
Dr. Dennis Moore's National Provider Identifier (NPI) is 1043272305, issued by NPPES.
Does Dr. Dennis Moore accept Medicare assignment?
Yes. Dr. Dennis Moore accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dennis Moore commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, aprepitant, 1 mg (HCPCS J0185). Source: CMS Medicare Physician & Other Practitioners file.